National Surveillance Data on the Epidemiology of Meningitis in Niger, 2005 - 2020

Alkassoum S. I. *

Département de Santé Publique, Université Abdou Moumouni, FSS, Niamey, Niger.

Abdoulaye Z.

Département de Santé Publique, Université Abdou Moumouni, FSS, Niamey, Niger.

Goni A.

Département de Santé Publique, Université de Zinder, Niger.

Amadou O.

Université Dan Dicko Dan Koulodo, Maradi, Niger.

Djibo A.

Département de Santé Publique, Université Abdou Moumouni, FSS, Niamey, Niger.

Emoud T.

Hopital Général de Référence, Niamey, Niger.

Ibrahim M. L.

Centre de Recherche Médicale et Sanitaire, Niamey Niger.

Adeossi E.

Département de Médecine et Spécialités Médicales, Université Abdou Moumouni, FSS, Niamey, Niger.

*Author to whom correspondence should be addressed.


Background: Bacterial meningitis is a major public health problem, especially in low-income countries. We analyzed national surveillance data and isolates from Niger to describe the epidemiology of bacterial meningitis from 2005 to 2020.

Methods: We conducted a retrospective study of nationwide case-based surveillance data of all reported meningitis cases in Niger from 2005 to 2020. Modified case definition was used to classify the cases.

Results: A total of 47,953 suspected meningitis cases and 3,276 deaths (CFR=6.83%) were reported, corresponding to an incidence of 189.01 cases per 100,000 population. The male represented 55.41% ( sex-ratio male : female = 1.30) and 40.52% were 5 -14 y. A total of 29,998 cases were reported through RNL, of which 10,979 (36.60%) were confirmed, of which 6,149 (56.01%), were confirmed by culture. The predominant organism identified was N. meningitidis serogroup A (33.91%). All regions reported meningitis cases and a consistent and substantial reduction was seen in confirmed NmA cases, with no cases occurring in the country after the completion of mass campaigns. Nevertheless, other pathogen species and Nm variants, including NmX, NmC, and Streptococcus pneumoniae, have become more prevalent.

Conclusion: Increased surveillance of multiple serogroups throughout is necessary, as well as consideration of vaccination with combination vaccines rather than just using a single strain as is currently the case with NmA.

Keywords: Bacterial meningitis, surveillance, epidemiology, outbreaks, Niger

How to Cite

Alkassoum S. I., Abdoulaye Z., Goni A., Amadou O., Djibo A., Emoud T., Ibrahim M. L., & Adeossi E. (2024). National Surveillance Data on the Epidemiology of Meningitis in Niger, 2005 - 2020. International Journal of TROPICAL DISEASE & Health, 45(2), 1–9.


Download data is not yet available.


McGill F, Heyderman RS, Panagiotou S, Tunkel AR, Solomon T. Acute bacterial meningitis in adults. Lancet. 2016;388 (10063):3036-3047. DOI: 10.1016/S0140-6736(16)30654-7

Hill DJ, Griffiths NJ, Borodina E, Virji M. Cellular and molecular biology of Neisseria meningitidis colonization and invasive disease. Clin Sci (Lond). 2010;118(9):547-564. Doi: 10.1042/CS20090513

Ali G, Roham S, Parsa Y, Abolfazl G. Streptococcus Viridans meningitis in an immunocompetent child: A case report. Clin Case Rep. 2023;11(3): 11e7058. DOI: org/10.1002/ccr3.7058

Uduman SA, Adeyemi E, El-Khadir A, Jose K, Benedict S, Bener A. Haemophilus influenzae type b still remains a leading cause of meningitis among unvaccinated children--a prospective CSF analysis study. J Trop Pediatr. 2000;46(6):331-334. DOI: 10.1093/tropej/46.6.331

Ramachandran P, Fitzwater SP, Aneja S, et al. Prospective multicentre sentinel surveillance for Haemophilus influenzae type b & other bacterial meningitis in Indian children. Indian J Med Res. 2013;137 (4):712-720.

Goetghebuer T, West TE, Wermenbol V, et al. Outcome of meningitis caused by Streptococcus pneumoniae and Haemophilus influenzae type b in children in The Gambia. Trop Med Int Health. 2000 ;5(3):207-213. DOI: 10.1046/j.1365-3156.2000.00535.x

Barichello T, Rocha Catalão CH, Rohlwink UK, et al. Bacterial meningitis in Africa. Front Neurol. 2023;14:822575. DOI: 10.3389/fneur.2023.822575

WHO. Control of epidemic meningitis in countries in the African meningitis belt, 2020. Weekly epidemiological Records. 2020;32(96):365–376.

Mazamay S, Guégan JF, Diallo N, et al. An overview of bacterial meningitis epidemics in Africa from 1928 to 2018 with a focus on epidemics "outside-the-belt". BMC Infect Dis. 2021;21(1):1027. DOI: 10.1186/s12879-021-06724-1

Sow SO, Okoko BJ, Diallo A, et al. Immunogenicity and safety of a meningococcal A conjugate vaccine in Africans. N Engl J Med. 2011;364(24): 2293-2304. DOI: 10.1056/NEJMoa1003812

Kristiansen PA, Diomandé F, Ba AK et al. Impact of the serogroup A meningococcal conjugate MenAfriVac, on carriage and herd immunity. Clinical Infectious disease; 2012.

Viviani S. Efficacy and Effectiveness of the Meningococcal conjugate group A vaccine menafrivac® in preventing recurrent meningitis epidemics in Sub-Saharan Africa. Vaccines (Basel). 2022;10 (4):617. DOI: 10.3390/vaccines10040617

LaForce FM, Djingarey M, Viviani S, Preziosi MP. Successful African introduction of a new Group A meningococcal conjugate vaccine: Future challenges and next steps. Hum Vaccin Immunother. 2018;14(5):1098-1102. DOI: 10.1080/21645515.2017.1378841

World Health Organization. Meningococcal disease in countries of the African meningitis belt, 2012–emerging needs and future perspectives. Weekly Epidemiological Records. 2013;88(12): 129-136.

MSP/DSRE. Evaluation de l'epidmie de Meningite en 2017. Niamey : s.n; 2017.

OMS. Rapidly growing outbreak of meningococcal disease in Niger. [En ligne]; 2015. Available :

[Accessed on: 19 11 2022.]

MacNeil JR, Medah I, Koussoubé D, Novak RT, Cohn AC, Diomandé FV, Yelbeogo D, Kambou JL, Tarbangdo TF, Ouédraogo-Traoré R, Sangaré L. Neisseria meningitidis serogroup W, Burkina Faso, 2012. Emerging infectious diseases. 2014;20(3):394.

Lapeyssonnie L. La meningite cerebrospinale en Afrique. Bull World Health Organ. 1963;28 Suppl(Suppl):1-114.

Molesworth AM, Cuevas LE, Connor SJ, Morse AP, Thomson MC. Environmental risk and meningitis epidemics in Africa. Emerg Infect Dis. 2003;9(10):1287-1293. DOI: 10.3201/eid0910.030182

Boisier P, Mainassara HB, Sidikou F, Djibo S, Kairo KK,. Case fatality ratio of bacterial meningitis in the African meningitis belt: we can do better. Vaccine. 2007;25 Suppl 1:A24-A29. DOI:10.1016/j.vaccine.2007.04.03

Sultan B, Labadi K, Guégan JF, Janicot S. Climate drives the meningitis epidemics onset in west Africa. PLoS Med. 2005;2(1):e6. DOI:10.1371/journal.pmed.0020006

Agier L, Deroubaix A, Martiny N, Yaka P, Djibo A, Broutin H. Seasonality of meningitis in Africa and climate forcing: aerosols stand out. J R Soc Interface. 2012;10(79):20120814. DOI: 10.1098/rsif.2012.0814 Accessed on: 2012 Dec 5.

Martiny N, Chiapello I. Assessment for the impact of mineral dust on meningitis incidence in West Africa. Atmos Environ. 2013;70:245–53. DOI. org/ 10. 1016/j. atmos env. 2013. 01. 016

García-Pando CP, Thomson MC, Stanton MC. et al. Meningitis and climate: From science to practice. Earth Perspectives. 2014;1:14.

Paireau J, Maïnassara HB, Jusot JF, et al. Spatio-temporal factors associated with meningococcal meningitis annual incidence at the health centre level in Niger. 2004-2010. PLoS Negl Trop Dis. 2014;8(5):e2899. DOI: 10.1371/journal.pntd.0002899

Woringer M, Martiny N, Porgho S, Bicaba BW, Bar-Hen A, Mueller JE. Atmospheric Dust, Early Cases, and Localized Meningitis Epidemics in the African Meningitis Belt: An Analysis Using High Spatial Resolution Data. Environ Health Perspect. 2018;126(9):97002. DOI: 10.1289/EHP2752

Jafri RZ, Ali A, Messonnier NE et al. Global epidemiology of invasive meningococcal disease. Popul Health Metr. 2013;11(1): 17. DOI: 10.1186/1478-7954-11-17 Accessed on: 2013 Sep 10.

Mueller JE, Gessner BD. A hypothetical explanatory m proportion of meningococcal meningitis in the African meningitis belt. Int J Infect Dis. 2010;14(7):e553-e559. DOI: 10.1016/j.ijid.2009.08.013

Shikanga OT, Mutonga D, Abade M, et al. High mortality in a cholera outbreak in western Kenya after post-election violence in 2008. Am J Trop Med Hyg. 2009;81(6):1085-1090 DOI: 10.4269/ajtmh.2009.09-0400

Chippaux JP, Debois H, Saliou P. Critical review of control strategies for meningococcal meningitis epidemics in Sub-Saharan Africa. Bull Soc Pathol Exot. 2002;95(1):37-44

Oordt-Speets AM, Bolijn R, van Hoorn RC, Bhavsar A, Kyaw MH. Global etiology of bacterial meningitis: A systematic review and meta- analysis. . . . . PLoS ONE. 2018;13(6):e0198772. Available:

Lewis R, Nathan N, Diarra L, Belanger F, Paquet C. Timely detection of meningococcal meningitis epidemics in Africa. The Lancet. 2001;358(9278):287–293. DOI:10.1016/S0140-6736(01)05484-8

Caroline LT, Clement L, Katya F, Laura VC, et al . The impact of MenAfriVac in nine countries of the African meningitis belt, 2010-2015: An analysis of surveillance data. Lancet Infect Dis. . . . 2017;17(8):867-8. DOI:10.1016/S1473-3099(17)30301-8

Xie O, Pollard AJ, Mueller JE, Norheim G. Emergence of serogroup X meningococcal disease in Africa: the need for a vaccine. Vaccine. 2013;31(27):2852–2861. DOI: 10.1016/vaccine.2013.04.036

Delrieu I, Yaro S, Tamekloe TA, et al. Emergence of epidemic Neisseria meningitidis serogroup X meningitis in Togo and Burkina Faso. PLoS One. 2011; 6(5):e19513. DOI: 10.1371/journal.pone.00195